发明名称 ncRNA AND USES THEREOF
摘要 The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to ncRNAs as diagnostic markers and clinical targets for prostate, lung, breast and pancreatic cancer.
申请公布号 US2015284802(A1) 申请公布日期 2015.10.08
申请号 US201113299000 申请日期 2011.11.17
申请人 Chinnaiyan Arul;Prensner John;Iyer Matthew 发明人 Chinnaiyan Arul;Prensner John;Iyer Matthew
分类号 C12Q1/68 主分类号 C12Q1/68
代理机构 代理人
主权项 1. A method of screening for the presence of prostate cancer in a subject, comprising (a) obtaining a sample from a subject suspected of having prostate cancer, wherein the sample comprises prostate cancer associated non-coding RNAs (ncRNA); (b) processing the sample to isolate or enrich the sample for ncRNA or cells containing ncRNA; and (c) detecting the level of expression of said ncRNA in said sample by sequencing, nucleic acid hybridization or nucleic acid amplification,wherein said ncRNA is PCAT1, and wherein an increased level of expression of said ncRNA in said sample relative to the level in normal prostate cells is indicative of prostate cancer in said subject.
地址 Plymouth MI US